TPW
PRCT icon

Transatlantique Private Wealth’s Procept Biorobotics PRCT Stock Holding History

Transatlantique Private Wealth’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.73M Hold
118,436
– – 1.17% 18
2025
Q3 		$4.23M Hold
118,436
– – 1.38% 13
2025
Q2 		$6.82M Hold
118,436
– – 2.51% 4
2025
Q1 		$6.9M Hold
118,436
– – 2.75% 3
2024
Q4 		$9.54M Sell
118,436
-26,175
-18% -$2.24M 3.62% 3
2024
Q3 		$11.6M Sell
144,611
-5,389
-4% -$383K 4.43% 2
2024
Q2 		$9.16M Buy
+150,000
New +$8.92M 3.74% 3

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Transatlantique Private Wealth's PRCT Position: Q4 2025 in Review

Transatlantique Private Wealth held its Procept Biorobotics (PRCT) position steady in Q4 2025 at 118,436 shares worth $3.73M. The position accounts for 1.17% of the portfolio, ranked #18.

Transatlantique Private Wealth first reported a position in PRCT in Q2 2024 and has held it in 7 quarters since. The position peaked at $11.6M in Q3 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Transatlantique Private Wealth held 118,436 shares of Procept Biorobotics worth $3.73M as of Q4 2025.
  • Transatlantique Private Wealth left its Procept Biorobotics share count unchanged in Q4 2025.
  • Procept Biorobotics made up 1.17% of Transatlantique Private Wealth's portfolio in Q4 2025, its #18 holding.
  • Transatlantique Private Wealth first reported a position in Procept Biorobotics in Q2 2024 and has held it in 7 quarters since.
  • Transatlantique Private Wealth's Procept Biorobotics position peaked at $11.6M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.